TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets
Lowe, Devin B., Bivens, Camille K., Mobley, Alexis S., Herrera, Christian E., McCormick, Amanda L., Wichner, Timea, Sabnani, Manoj K., Wood, Laurence M., Weidanz, Jon A.
Published in mAbs (19.05.2017)
Published in mAbs (19.05.2017)
Get full text
Journal Article
TCR-like antibody duocarmycin conjugates promote cytotoxicity of tumor cells expressing low peptide/HLA targets
Herrera, Christian E, Lowe, Devin B, Bivens, Camille K, Mobley, Alexis S, McCormick, Amanda, Wichner, Timea, Sabnani, Manoj K, Wood, Laurence M, Weidanz, Jon A
Published in The Journal of immunology (1950) (01.05.2017)
Published in The Journal of immunology (1950) (01.05.2017)
Get full text
Journal Article